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Abstract
BBACKGROUND: The aim of this paper was to analyse our own semi-quantitative method of assessing focal lesions localised 
in pre-operative diagnostic scintigraphy of primary hyperparathyroidism (PHPT) using 99mTc-MIBI with washout and comparing 
these data with the result of the histopathological examination (HP).
MATERIAL AND METHODS: A total of 40 (37 female, 3 male, average age 58.7 years) patients with a suspicion of PHPT were 
enrolled for prospective analysis. Dual phase planar and SPECT/CT examination with 99mTc-MIBI were performed. The tumour 
to background ratios in the 10th and 120th minute were calculated (TBR10 and TBR120) on the basis of the planar acquisition. 
PTH, ionised calcium and phosphate levels were measured.
Parathyroid surgery alone or combined with subtotal/total thyreoidectomy was conducted in 23 (57.5%) and 17 (42.5%) patients, 
respectively. A HP was performed in all patients.
RESULTS: Average concentration of PTH in the whole group was 243.95 pg/ml.
There was a statistically significant correlation between medians of PTH concentration and parathyroid histopathological results 
(p = 0.01).
A total of 45 lesions of increased uptake were found in 32 (80.0%) and 34 (85%) patients in the early phase and the delayed 
phase, respectively.
The post-operative material contained 20 (44.5%) parathyroid adenomas, 11 (24.5%) cases of hyperplasia, 2 (4.4%) cancers, 
4 (8.9%) cases of normal parathyroid tissue, 2 (4.4%) lymph nodes and 6 (13.3%) cases of thyroid gland tissue.
The medians of TBR10 and TBR120 for lesions examined in the HP were respectively: 3.64 and 2.59 for adenoma; 3.08 and 
2.18 for hyperplasia; 7.7 and 5.5 for parathyroid cancer, 4.89 and 3.16 for normal tissue and 5.26 and 2.95 for lymph nodes 
or thyroid gland tissue.
A high correlation coefficient of TBR10 to TBR120 in the parathyroid adenoma and parathyroid hyperplasia groups was observed 
with r = 0.867 and r = 0.964, respectively. The ρr correlation coefficient of TBR10 to TBR120 for normal parathyroid was 0.4.
There was a statistically significant association between the HP and TBR10 medians (p = 0.047), but not between histopathol-
ogy and TBR120 medians (p = 0.840).
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Background
Primary hyperparathyroidism (PHPT) causes a disturbance in 
the metabolism of calcium due to excessive secretion of PTH. It 
affects 1 in 500 women and 1 in 1000 men, usually between the 
fifth and seventh decade of life. Approximately 80% of cases of 
this disease are a result of a solitary parathyroid adenoma. The suc-
cess rate in surgical treatment is high on condition that localisation 
diagnostics are accurate [1].
The diagnosis of primary hyperparathyroidism is based on 
clinical, laboratory assessment and imaging modalities such as ul-
trasonography and scintigraphy. In the majority of cases, a single 
not palpable focal lesion is seen, quite often on ultrasonography, 
but it should be verified in scintigraphy [2, 3]. Surgical intervention 
is conditional upon visualization of the lesion with the increased 
metabolic activity. It may happen that identifying a lesion is not 
a guarantee of success in surgery. After a histopathology examina-
tion the result may show no parathyroid tissue, even if all preopera-
tive data was collected and surgical procedures were followed [4].
Parathyroid scintigraphy is a very important diagnostic tool 
when suspecting parathyroid adenoma. It is performed with the 
use of 99mTc-MIBI (2-methoxy-isobutyl-isonitril). This compound 
is treated by transport proteins as a xenobiotic. Depending on 
protein activity this tracer may be washed out, remain stable or be 
retained by transport proteins in the cell [5].
Contemporary methods of diagnostics imaging allow an in-
creasing degree of quantification of the occurring pathologies. 
Different protocols of parathyroid scintigraphic examination are 
used for semi-quantitative assessment of lesions, among them 
dual phase examination (washout technique) [6].
Various techniques have been used in parathyroid research 
to assess metabolic activity of focal lesions, but few authors have 
analysed the relationship between scintigraphic image data and the 
results of the histopathological examination in a prospective study [7].
The aim of this paper was to analyse our own semi-quantitative 
method of assessing focal lesions localised in pre-operative diag-
nostic scintigraphy of PHPT using 99mTc-Sestamibi with washout 
and comparing these data with the result of the histopathological 
examination.
Material and methods
A total 40 patients aged 27 to 81 (mean 58.4 years) with 
a suspicion of PHPT were enrolled for the prospective study and 
examined using parathyroid scintigraphy. 37 of the patients (92.5%) 
were female and 3 were male (7.5%). Subsequently, on the basis of 
a positive scintigraphy which confirmed the focal lesion of increased 
metabolic activity, they were operated on in two surgical wards that 
collaborated with the Department of Nuclear Medicine. All pa-
tients expressed their written consent for participation in the study.
On the day of scintigraphy, parathormone (PTH) concentra-
tion, ionised calcium and inorganic phosphate were measured in 
patients on an empty stomach.
All patients had planar scintigraphy of the parathyroid and 
a SPECT/CT scan 10 minutes and two hours from administering 
720M Bq of 99mTc-MIBI. The washout technique was used (one 
tracer, two phases). Mean time between phases was 127.24 min.
The examination was performed using a gamma camera GE 
INFINIA Hawkeye 4 with a LEHR (Low Energy High Resolution) 
collimator and 2.0 zoom. The field of vision included the neck 
and mediastinum in a posterior-anterior projection. A 256 × 256 
pixel matrix was used. Planar acquisition was conducted up to 
the point of obtaining 700 kcounts. The energy window was 140 
keV ± 5%.
A macro function was created for planar acquisition, which 
enabled standardising calculations by selecting an appropriate 
background region of interest for the identified focal lesions. An 
automatic calculation of the tumour to background counts ratio 
was obtained for early and delayed phase (TBR 10 and TBR 120). 
Moreover, the method allowed obtaining a repeatable distance 
between the background and the tumour in all described loca-
tions and differentiating size and contour of background from the 
size and contour of the tumour.
Four identical macro functions for superior and inferior para-
thyroid on the right and left side were computed. All data were 
automatically adjusted for radioactive decay according to the decay 
rate of 99mTc (Figure 1, 2).
The results of scintigraphy were prospectively consulted with 
a team of surgeons before surgical treatment. Parathyroidectomy 
was performed in 23 (57.5%) patients, whilst in 17 (42.5%) pa-
tients surgery additionally involved complete or partial thyroidec-
tomy. The rationale for expanding the procedure into the thyroid 
gland were concomitant focal lesions. After the procedure, removed 
tissue was secured and after recording its location transferred to 
two pathology departments that cooperated with the Division of 
Nuclear Medicine. At further stages of the study,the results of the 
histopathological examination were retrospectively analysed and 
compared with biochemical data and scintigraphic findings.
In 27 patients, PTH assays were performed after the surgical 
procedure. No intra-operative PTH assays were performed.
CONCLUSIONS: The washout technique in pre-operative 99mTc-MIBI scintigraphy is effective in detecting lesions of the para-
thyroid (cancer, adenoma, hyperplasia, normal tissue of the parathyroid).
Parathyroid cancers in semi-quantitative analysis were characterised by a slightly higher TBR. However, it is impossible to 
differentiate lesions based on this data.
Histopathology results are significantly associated with TBR and PTH. 
KEY words: hyperparathyroidism, adenoma, localization, nuclear scanning, sestamibi
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The normality of distribution for continuous variables was ex-
amined by the Kolomogorov-Smirnov test. Correlations between 
variables were examined with the Spearman test. The Wilcoxon test 
was used for comparing pairs of dependent observations while 
larger groups of independent observations were compared using 
the Kruskal-Wallis test. Statistical analysis was performed with IBM 
SPSS 23, the threshold for statistical significance was p < 0.05.
Results
Scintigraphy revealed 45 lesions of focally increased accu-
mulation of the radiopharmaceutical. Two foci were found in three 
patients, three foci in one patient.
A foci of pathological tracer accumulation were found in 
32 (80.0%) patients in the early phase and 34 (85.0%) patients in the 
delayed phase. A positive result in both phases of planar acquisition 
was recorded in 37 (92.5%) patients and negative in 3 patients (7.5%); 
however, the SPECT/CT result was positive in the latter group.
Average concentrations in the whole group were as follows: 
PTH 243.95 pg/ml (reference range15–65 pg/mL), ionised calcium 
1.49 mmol/L (reference range 1.05–1.35 mmol/L), phosphate 
0.9 mmol/L (reference range 0.87–1.45 mmol/L). Detailed data are 
presented in Table 1.
45 (97.82%) lesions that were observed on scintigraphy 
and removed during surgery were assessed histopathologi-
cally. This group comprised 20 (44.5%) parathyroid adenomas, 
11 (24.5%) cases of parathyroid hyperplasia, 2 (4.4%) parathyroid 
cancers, 4 (8.9%) cases of normal parathyroid tissue, 2 (4.4%) 
lymph nodes and 6 (13.3%) cases of thyroid gland tissue.
The histopathology of the patient with three focal lesions on 
scintigraphy revealed presence of thyroid gland tissue in each of 
the specimens. In patients with two focal lesions the histopathologi-
cal examination revealed parathyroid hyperplasia and lymph node 
tissue; normal parathyroid and lymph node tissue; parathyroid 
adenoma and thyroid gland tissue, respectively.
The correlation between medians of preoperative PTH concentra-
tion and abnormal histopathological results was statistically significant 
Figure 1. Example of a focal lesion and automatically determined background in the projection of the right superior pole of the thyroid lobe in early 
and delayed phase, TBR 10 = 6.661, TBR 120 = 3.992. Adenoma of superior right parathyroid in a histopathological examination of a 73-year-old 
female patientutomatic
Figure 2. An example of a focal lesion and automatically determined background in the projection of the left thyroid lobe in early and delayed 
phase, TBR 10 = 13.112, TBR 120 = 9.027. Parathyroid cancer in a histopathological examination of a 73-year-old female patient
Table 1. Biochemical findings in the whole group before surgery
Data Min Max Average 
(± SD)
Median  
(Q25–Q75)
p*
Parathormone 
[pg/mL]
662.21 1699 243.95 
(± 317.5)
141 
(103–236.9)
0.004
Ionised calcium  
[mmol/L]
11.19 1.9 1.49 
(± 0.17)
1.46 
(1.35-1.62)
0.449
Phosphorus  
[mmol/L]
00.5 2.6 0.9 
(± 0.36)
0.8 
(0.7-0.97)
0.009
*p-value for normal distribution; SD — standard deviation
Background 10
Background 120
Early phase Delayed phase
Tumour 10 Tumour 120
Background 10
Early phase
Tumour 10
Background 120
Delayed phase
Tumour 120
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(p = 0.008). After including post-operative material with normal 
parathyroid tissue the result was still statistically significant (p = 0.01).
Out of 37 patients with a positive result of the planar examina-
tion the decrease of PTH concentration was found in 25 out of 26 
assays; in one case PTH concentration after surgery did not fall. 
The decrease of biochemical markers after surgery was recorded in 
1 of 3 cases with a negative result of the planar examination. Both 
surgical centres did not have the possibility of intraoperative assess-
ment of PTH concentration and hence these measurements were 
performed postoperatively. Postoperative PTH assays were not 
performed in 13 patients.
Histopathologically, 35 lesions identified on scintigraphy were 
verified as true positive (TP) and proved to be adenoma (19 cases), 
hyperplasia (10 cases), cancer (2 cases) and normal parathyroid 
gland tissue (4 cases). Normal parathyroid glands were considered 
as TP because they were visible on a scan and appeared to be 
visually dubious for the surgeon.
Histopathological verification revealed five lesions positive in 
planar examination but negative on HP (false positive, FP), five 
lesions not found in planar examination of which two lesions were 
an adenoma and hyperplasia, respectively (false negative, FN), 
three were normal thyroid gland tissue (true negative, TN). Le-
sions not found in planar examination could not serve for TBR 
calculation on a planar scan.
There were three other lesions without a TBR result. Two le-
sions were visible on the planar scan and mentioned in the descrip-
tive section of the scintigraphy report but they were not indicated 
as parathyroid abnormality in the definitive report conclusions. HP 
of those lesions confirmed thyroid gland tissue and lymph node, re-
spectively. The last lesion without related TBR bordered parathyroid 
hyperplasia. Specific calculation was abandoned due to overlap 
between both lesions. This lesion was HP verified as lymph node. 
Altogether 37 TBR ratio were calculated.
The total sensitivity of the method was estimated to be 94.6%, 
with a specificity of 37.5%, positive and negative predictive value of 
87.5% and 60.0%, respectively and an accuracy of 84.4%.
Figure 3 presents the median of tumour/background coef-
ficients TBR 10 and TBR 120 obtained during planar scintigraphy, 
corresponding histopathological diagnoses and the statistical 
relationships between them.
A high correlation coefficient of TBR 10 to TBR 120 in the 
parathyroid adenoma and parathyroid hyperplasia groups was ob-
served, with r = 0.867 and r = 0.964, respectively. The r correlation 
coefficient of TBR 10 to TBR 120 for normal parathyroid was 0.4. 
Figure 3. Median of TBR coefficients in the 10th and 120th minute of parathyroid scintigraphic examination and corresponding histopathological 
diagnoses; *statistical significance a = 0.05
Table 2. Parathormon (PTH) values with corresponding histopathological diagnosis
Histopathological diagnosis Parathyroid  
cancer
Parathyroid  
adenoma
Parathyroid  
hyperplasia
Normal  
parathyroid
Other (thyroid,  
lymph node)
PTH [pg/mL] Median 
(Q25–Q75)
339.75
(306.88–372.63)
173.10 
(119.15–354.70)
125.8 
(98.2–140.2)
130.8 
(118.75–140.95)
103 
(84.78–141.3)
0
1
2
3
4
5
6
7
8
9
Parathyroid 
adenoma 
n = 19 
p < 0.001*
Parathyroid 
hyperplasia 
n = 10 
p < 0.005*
Parathyroid 
cancer 
n = 2 
p < 0.180*
Parathyroid 
adenoma 
n = 4 
p < 0.068*
Parathyroid 
adenoma 
n = 2 
p < 0.180*
TBR 10                       TBR 120
3.64
2.59
3.64
2.59
7.77
5.5
4.89
3.16
5.26
2.95
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The analysis did not include cases of parathyroid cancer due to 
their small number (two cases).
As regards TBR medians for all five HP diagnoses, statistical 
significance was found for TBR 10 medians (p = 0.047), but not 
for TBR 120 medians (p = 0.840).
When the relationship between the subgroup of abnormal 
(cancers, adenomas and hyperplasias) HP diagnoses and the 
subgroup that included normal parathyroid tissue and other HP 
diagnoses was examined, the result remained statistically signifi-
cant for TBR 10 medians (p = 0.021) but not for TBR 120 medi-
ans (p = 0.604). Unfortunately, there were very few patients with 
normal parathyroid and conclusions drawn from these data may 
be overestimated.
Discussion
Quantitative approach to the analysis of the results in nuclear 
medicine has a long-standing tradition, particularly as far as planar 
examination is concerned. The assessment of tumour size and 
intensiveness of tracer accumulation are especially important in 
oncology. Researchers have sought a relationship between the 
obtained images and their quantitative assessment in hope that 
there would be a possibility of using such information in clinical 
practice. The radiotracer uptake is usually associated with a specific 
metabolic feature specified in the scintigraphic examination. It may 
be related to, for example, osteoblastic activity in the bone, activity 
of renal parenchyma, or, as in parathyroid scintigraphy, metabolic 
activity of a parathyroid tumour.
In this study, performed with dual-phase 99mTc-MIBI scintigraphy, 
we present a method of calculating the tumour-to-background ratio 
(TBR), based on the assumption that the number of counts in the 
background region is subtracted from the number of counts in the 
tumour region, depending on the contour and size of the tumour and 
its location. It should also be noted that the distance between the 
region of the tumour and the region of the background remains con-
stant. In addition, a correction was introduced in the delayed phase 
to adjust for radioactive decay of the 99mTc isotope. The authors of 
the present study did not find a similar approach in the literature, 
although there have been attempts at evaluating the metabolic 
activity of the tumour as measured by the tumour/background ratio. 
The diagnostics of PHPT usually identifies adenoma, hyperplasia 
and cancer cases. The correlation between TBR 10 and TBR 120 
in patients with adenoma or hyperplasia was much higher than for 
normal parathyroid: r = 0.867, r = 0.964 and r = 0.400, respectively.
Little information has been found when searching for 
semi-quantitative data on the metabolic activity of histopathologi-
cally normal parathyroid, thyroid gland and lymph node tissue [7]. 
The present study isolated five histopathological diagnosis groups. 
This allowed conducting a semi-quantitative analysis based on the 
histopathological diagnosis, which is undoubtedly an advantage 
of the presented analysis.
Cheon et al. presents a retrospective attempt at differentiating 
between benign and malignant lesions on the basis of double 
phase scintigraphy with 99mTc-MIBI in patients with PHPT. The find-
ings were evaluated using a four-point visual scale based on the 
comparison of tracer accumulation in the submandibular gland and 
thyroid gland as opposed to the parathyroid. The high uptake of 
radiotracer in the delayed phase and small difference in radioactivity 
between early and delayed uptake were among the combinations of 
different factors that proved useful in determining the highest pos-
sible positive predictive value for detecting a neoplastic lesions [8].
In an earlier publication, Takebayashi et al. used a retrospective 
semiquantitative analysis to correlate the results of the histopatho-
logical examination with double phase 99mTc-MIBI scintigraphy in 
primary and secondary hyperparathyroidism. They demonstrated 
an association between uptake of oncophilic tracer and the size 
of the tumour and its histological structure (chief cells and oxy-
philic cells). The analysis was based on the parathyroid-to-thyroid 
counts ratio. There was no significant association between data de-
scribing early and delayed image in any of the 11 cases of PHPT [7].
Qiu et al. performed a retrospective analysis of planar scinti-
graphic images of patients with PHPT obtained using the double 
phase method, also used by the authors of this paper. A positive 
result was defined as increased accumulation of 99mTc-MIBI in the 
delayed phase when compared to the early phase. A negative 
result was defined as lack of 99mTc-MIBI uptake when compared 
to the background. Only visual assessment was used, without 
a numerical scale [5].
The analysis of literature demonstrated that the rate of positive 
results in the double phase planar scintigraphy had been steadily 
increasing. In 1999 Takebayashi et al. reported 52.4% positive pla-
nar examinations, in 2001 Scheiner et al. reported 64.5%, in 2012 
Akbaba et al. obtained 67.3%, whereas papers published in 2014 
by Noda et al. and Qiu et al. give 85.2% and 71.31%, respectively 
[2, 7, 9, 10].
In the present study, planar examinations were positive in 
92.5% of patients. Close cooperation with surgeons (feedback after 
surgery), the author’s considerable experience and scintigraphy 
acquisition parameters might have all played a role in achieving 
such high rate of positive examinations.
The authors of the present study have observed that the me-
dians of pre-operative PTH concentrations in patients with PHPT 
range from 83 to 434 pg/mL [11–15]. Cheon et al. observed that 
there is a statistically significant difference between PTH concen-
trations in blood serum of patients with parathyroid adenoma and 
with parathyroid cancer. Patients with a confirmed parathyroid 
cancer usually have a higher concentration of PTH in blood serum. 
This is consistent with our observations and with findings in subject 
literature [8, 16–18].
In this study, the median of PTH concentrations was 
141 pg/mL, which does not diverge from the results presented in 
Wei et al.’s meta-analysis [19]. Cancers of the parathyroid gland are 
usually characterised by higher PTH concentration. In our case the 
medians of PTH concentrations for parathyroid cancer were also 
the highest and differed significantly from other histopathological 
diagnoses [20].
In the meta-analysis by Wei et al. from 2015,18 publica-
tions about parathyroid scintigraphy were evaluated. The 
authors compared different scintigraphic modalities that used 
99mTc-MIBI (planar examination, SPECT-CT, SPECT) to investi-
gate their usefulness for minimal invasive parathyroidectomy in 
patients with PHPT. They concluded that planar examinations on 
average had a sensitivity of 63% (95% CI: 51–74%) and a positive 
predictive value of 90% (95% CI: 96–99%) [19]. Sensitivity of double 
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phase examination in the cited publications ranged from 44% to 
87.5% when using a 128 × 128 matrix and 59.18% to 76%. When 
using a 256 × 256 matrix for planar examination [14, 21–23].
By following the algorithm developed by the authors a sensitivity 
of 94.6% was achieved in the presented method. Positive predictive 
value was 87.5%, which is similar to average values in the literature. 
Moreover, it is important to mention that owing to the prospective 
process of patient enrolment and to histopathological confirmation 
as the gold standard it was possible to assess specificity, negative 
predictive value and accuracy of the method.
Currently the only possibility of calculating these para- 
meters is planar examination since SPECT requires a much more 
advanced mathematical approach that would entail measuring 
counts in a 3D environment. The task presents an additional ob-
stacle due to the close vicinity of the thyroid gland which affects the 
precision of the examination (pinpointing voxel position) [24]. In 
these circumstances proposing a relatively simple, repeatable 
method of focal lesion metabolic activity assessment, as is the case 
with TBR, allows a much more precise differentiation of these foci.
Conclusions
The washout technique in pre-operative 99mTc-MIBI scintigraphy 
is effective in detecting lesions of the parathyroid (cancer, adenoma, 
hyperplasia, normal tissue of the parathyroid).
Parathyroid cancers in semi-quantitative analysis were char-
acterised by a slightly higher TBR. However, it is impossible to 
differentiate lesions based on this data.
Histopathology results are significantly associated with TBR 
and PTH.
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